| Literature DB >> 34905629 |
R Hoare1, K Shahin1,2, K McLean3, A Adams1.
Abstract
Entities:
Keywords: zzm321990Flavobacterium psychrophilumzzm321990; immersion challenge; immersion vaccination; proteomics; rainbow trout; skin mucus
Mesh:
Year: 2021 PMID: 34905629 PMCID: PMC9299601 DOI: 10.1111/jfd.13562
Source DB: PubMed Journal: J Fish Dis ISSN: 0140-7775 Impact factor: 2.580
FIGURE 12D gel electropherograms of mucus (60 µg protein) indicating protein spots that were excised and used for mass spectrometry analysis. Spot 1 was identified as annexin A5‐like (NM 34.7); spot 2 was identified as annexin A1‐like (NM: 37.2). Mucus was isolated from rainbow trout vaccinated with Flavobacterium. psychrophilum (A: non‐vaccinated; B: vaccinated) post‐immersion challenge with virulent F. psychrophilum (AVU‐1T/07). For more information including Mascot scores and pI, see Table S1. Duplicate gels were run for each treatment group as technical replicates
FIGURE 22D gel electropherograms of mucus (60 µg protein) indicating protein spots that were excised and used for mass spectrometry analysis (spots 3–5). Mucus was isolated from unvaccinated rainbow trout challenged with F. psychrophilum by: (A) immersion and (B) intramuscular injection. The large blue circle indicates significantly different spots observed on gel A (immersion‐challenged) but not on gel B (injection‐challenged) with insufficient protein present to be analysed by MS. For more information including Mascot scores and pI, see Table S1. Duplicate gels were run for each treatment group as technical replicates
Mucus proteins identified by mass spectrophotometry following vaccination and/or challenge
| Spot | Protein (BLAST) | Nominal Mass | ~ p | Sequence coverage | Mascot scores | Spot intensity | Stats (ANOVA) | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Immersion‐vaccinated (non‐challenged) | Immersion‐unvaccinated (non‐challenged) | I.P. injection‐challenged (unvaccinated) | Immersion‐challenged (unvaccinated) | |||||||
| 1 | Annexin A5‐like [ |
34,765.7 | 5.3 |
MS: 50.8% MS/MS: 8.5% | 103 | 35 | 22 | NA | NA | ** |
| 2 | Annexin A1‐like [ | 37,214.3 | 6.1 | MS: 54.6% | 143 | 71 | 49 | NA | NA | *** |
| 3 | Actin beta [ | 41,755.7 | 5.2 | MS: 39.2% | 74 | NA | NA | X | 74 | *** |
| 4 | Actin, cytoplasmic 1 isoform X1 [ | 42,966.4 | 5.4 | MS: 41.9% | 73 | NA | NA | X | 73 | *** |
| 5 | Actin beta [ | 41,755.7 | 5.2 | MS: 62.9% | 101 | NA | NA | X | 101 | *** |
MASCOT scores >61 are deemed significant. Asterisks denote significance difference between groups (vaccinated/unvaccinated; injection‐challenged/immersion‐challenged): *p < .05; **p < .01; ***p < .001; and ****p < .0001. X: absent and NA: not applicable.